| Type | Title | Date Released | |
|---|---|---|---|
144 | Form 144 | ||
144 | Form 144 | ||
3 | Bonuccelli Catherine M. (Reporting) | ||
3 | Valentine James Elwood (Reporting) | ||
3 | Wise John Drayton (Reporting) | ||
3 | Militello John (Reporting) | ||
3 | Fandrick Keith R. (Reporting) | ||
3 | PATTERSON LEONE D (Reporting) | ||
8-K | IRulya Therapeutics Highlights Clinical Pipeline and LAM-001 Progress for Rare Pulmonary Diseases | ||
SCHEDULE 13G | Foresite Capital Fund VI LP (Filed by) | ||
SCHEDULE 13G | PERCEPTIVE ADVISORS LLC (Filed by) | ||
8-K | Quince Therapeutics Relaunches as IRulya Therapeutics with Focus on LAM-001 for Pulmonary Diseases |
